Immediate Impact
61 standout
Citing Papers
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations
2024 Standout
Works of Andrea Ruzza being referenced
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
2020
Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andrea Ruzza | 794 | 268 | 213 | 45 | 936 | |
| Michel Zeitouni | 529 | 686 | 58 | 65 | 1.1k | |
| K Wenke | 608 | 344 | 27 | 29 | 767 | |
| Gabriella Iannuzzo | 393 | 328 | 40 | 70 | 916 | |
| Derek Connolly | 389 | 291 | 171 | 43 | 799 | |
| Sara C. Martinez | 532 | 404 | 29 | 31 | 1.1k | |
| Fabrice Ivanés | 234 | 551 | 35 | 49 | 967 | |
| Eralp Tutar | 354 | 445 | 18 | 41 | 939 | |
| Anastasia Lesogor | 616 | 526 | 153 | 23 | 1.1k | |
| Ragnhild Wergeland | 349 | 609 | 10 | 33 | 1.1k | |
| Lung‐Chih Li | 251 | 90 | 18 | 44 | 874 |
All Works
Login with ORCID to disown or claim papers
Loading papers...